Hairy cell leukemia, Classification of Tumours of Haematopietic and Lymphoid Tissues, 2008. ,
The 2016 revision of the World Health Organization classification of lymphoid neoplasms, Blood, vol.127, issue.20, pp.2375-90, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01800015
Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment, Cancer Treat Rev, vol.37, issue.1, pp.3-10, 2011. ,
Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?, Blood, vol.111, issue.4, pp.2253-2260, 2008. ,
Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes, Leuk Lymphoma, vol.14, issue.1, pp.57-61, 1994. ,
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia, Blood, vol.129, issue.5, pp.553-560, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02194198
Splenic B-cell lymphoma/leukemia unclassifiable, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 2008. ,
Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior, Blood, vol.114, issue.21, pp.4696-4702, 2009. ,
CD38 in hairy cell leukemia is a marker of poor prognosis and a new target for therapy, Cancer Res, vol.75, issue.18, p.5167, 2015. ,
VH4-341 hairy cell leukemia, a new variant with poor prognosis despite standard therapy, Blood, vol.114, issue.21, pp.4687-4695, 2009. ,
Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation ,
, Blood, vol.119, issue.14, pp.3330-3332, 2012.
BRAF mutations in hairy-cell leukemia, N Engl J Med, vol.364, issue.24, pp.2305-2315, 2011. ,
BRAF mutations in chronic lymphocytic leukemia, Leuk Lymphoma, vol.54, issue.6, pp.1177-1182, 2013. ,
Geissinger E. Alternative BRAF mutations in BRAF V600E-negative hairy cell leukaemias, Brit J Haematol, vol.165, issue.4, pp.529-562, 2014. ,
Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations, N Engl J Med, vol.373, issue.8, pp.726-736, 2015. ,
Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia, N Engl J Med, vol.373, issue.18, pp.1733-1747, 2015. ,
BRAF V600E mutation in hairy cell leukemia: from bench to bedside, Blood, vol.128, issue.15, pp.1918-1927, 2016. ,
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia, Sci Transl Med, 2014. ,
, , vol.6, pp.238-71
Langerhans cell histiocytosis in a patient with hairy cell leukemia: a tale of divergence, Blood, vol.129, issue.11, pp.1563-1563, 2017. ,
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim Chester disease in adults, Blood, vol.130, issue.2, pp.167-175, 2017. ,
High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias, Nat Genet, vol.46, issue.1, pp.8-10, 2014. ,
Recurrent CDKN1B (p27) mutations in hairy cell leukemia, Blood, vol.126, issue.8, pp.1005-1008, 2015. ,
Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations, Blood, vol.130, issue.14, pp.1644-1648, 2017. ,
Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma, Haematologica, vol.102, issue.10, pp.17558-1766, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01583112
Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation, Blood, vol.119, issue.1, pp.192-195, 2012. ,
Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations, Blood, vol.129, issue.8, pp.1042-1045, 2017. ,
Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies, Leuk Lymphoma, vol.58, issue.3, pp.666-675, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01795706
Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma, J Exp Med, vol.209, issue.9, pp.1553-1565, 2012. ,
The Kr? uppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma, Leukemia, vol.29, issue.2, pp.503-507, 2015. ,
Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity, Discov Medicine, vol.13, issue.71, pp.253-265, 2012. ,
Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis, J Comp Eff Res, vol.6, issue.6, pp.497-508, 2017. ,
ESMO Guidelines Committee. Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.26, issue.5, pp.100-107, 2015. ,
Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients, Brit J Haematol, vol.166, issue.1, pp.50-59, 2014. ,
BRAF V600E mutationspecific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia, Br J Haematol, vol.162, issue.6, pp.848-851, 2013. ,
Long-term follow-up after purine analogue therapy in hairy cell leukaemia, Best Pract Res Clin Haematol, vol.28, issue.4, pp.217-229, 2015. ,
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial, Br J Haematol, vol.174, issue.5, pp.760-766, 2016. ,
Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases, Ann Hematol, vol.94, issue.1, pp.89-95, 2015. ,
Obinutuzumab in multidrugresistant hairy cell leukemia, Ann Hematol, vol.95, issue.2, pp.351-352, 2016. ,
Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia, Ann Hematol, vol.93, issue.12, pp.1977-1983, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01699263
BRAF inhibition in refractory hairy-cell leukemia, N Engl J Med, vol.366, issue.21, pp.2038-2040, 2012. ,
BRAF inhibition in hairy cell leukemia with low dose vemurafenib, Blood, vol.127, issue.23, pp.2847-55, 2016. ,
Progression of RAS-Mutant Leukemia during RAF Inhibitor Treatment, N Engl J Med, vol.367, issue.24, pp.2316-2321, 2012. ,
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia, J Clin Invest, vol.124, issue.11, pp.5074-5084, 2014. ,
Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies, J Clin Oncol, vol.18, issue.8, pp.1622-1636, 2000. ,
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib, Blood, vol.125, issue.16, pp.2497-2506, 2015. ,
Current therapy and new directions in the treatment of hairy cell leukemia: a review, JAMA Oncol, vol.2, issue.1, pp.123-129, 2016. ,
Kreitman RJ. Bendamustine and rituximab in relapsed and refractory hairy cell leukemia, Clin Cancer Res, vol.19, issue.22, pp.6313-6321, 2013. ,
Fludarabine and rituximab for relapsed or refractory hairy cell leukemia, Blood, vol.119, issue.9, 2012. ,
Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia, Clin Cancer Res, vol.19, issue.24, pp.6873-6881, 2013. ,
Ibrutinib for relapsed refractory hairy cell leukemia variant, Leuk Lymphoma, vol.58, issue.5, pp.1224-1226, 2017. ,
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics, Nature, vol.490, issue.7418, pp.116-120, 2012. ,
How to cite this article: Troussard X, Cornet E. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment, Br J Haematol, vol.166, issue.3, pp.1382-1390, 2014. ,